Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Matthew W. Onaitis
Age : 47
Public asset : 107,930 USD
Linked companies : Cidara Therapeutics Inc
Summary 
Mr. Matthew W. Onaitis is CFO, CAO, Secretary & General Counsel at Cidara Therapeutics, Inc.

He is on the Board of Directors at Snp Bio, Inc. Mr. Onaitis was previously employed as Secretary & General Counsel by Ignyta, Inc., Secretary & General Counsel by Trius Therapeutics, Inc., Secretary, Senior Vice President & General Counsel by Somaxon Pharmaceuticals, Inc., Associate General Counsel by Biogen Idec, Inc., and Director-Legal Affairs by Elan Corp. Plc.

He received his undergraduate degree from Carnegie Mellon University and a graduate degree from Stanford Law School.


Current positions of Matthew W. Onaitis 
NameTitle Since
Snp Bio, Inc. Director -
Cidara Therapeutics Inc
(Biotechnology & Medical Research)
CFO, Secretary, CAO & General Counsel 2016


Holdings of Matthew W. Onaitis 
NameEquities%Valuation
Cidara Therapeutics Inc (CDTX)
Biotechnology & Medical Research
15,8720.078%113,485 USD


Matthew W. Onaitis: Personal Network 


Most Read News 
02/16 WARREN BUFFETT : Warren Buffett's Valentine's Day surprise for investors
02/13 STEPHEN SCHWARZMAN : Blackstone appoints real estate boss Gray as Schwarzman's successor
02/17 STEVE WYNN : Top Company News of the Day
02/15 PETER THIEL : Tech Luminary Peter Thiel Parts Ways With Silicon Valley
02/14 ROBIN LI : Baidu earnings beat forecasts, eyes U.S. listing for video unit iQiyi
02/16 ROMAN ABRAMOVICH : Co-owners of Russia's Nornickel back in fight for control
02/19 PETER THIEL : Top Company News of the Day
02/15 DAVID THOMSON : Thomson Reuters Chairman Criticized Its $17 Billion Deal with Blackstone
02/16 VINCENT BOLLORÉ : Vivendi shares drop as French group's lack of guidance underwhelms
02/13 STEVE WYNN : Top Company News of the Day
More news


© 2018 People and Ownership :   
Advertisement
Matthew W. Onaitis : Connections 
Villages of Indiana
College Bound Dorchester
Life Sciences Cares
Optimer Pharmaceuticals, Inc.
SV Health Investors LLC
Dana-Farber Cancer Institute, Inc.
Biomedical Sciences Careers Program, Inc.
Antimicrobials Working Group
Akili Interactive Labs, Inc.
The United States Pharmacopeia
Drake University



Popular Business Leaders 
Bernard Arnault Jean-michel Aulas Jeff Bezos Martin Blessing Kurt Bock Warren Buffett Jean-pierre Clamadieu Tim Cook Richard Cousins Elmar Degenhart Michael Dell Jamie Dimon Patrick Drahi Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Ingvar Kamprad Dara Khosrowshahi Isabelle Kocher Bruno Lafont Daniel Loeb Jack Ma Gérard Mestrallet Laurent Mignon Lakshmi Mittal Rupert Murdoch Elon Musk Michael O'leary Nelson Peltz Sumner Redstone Alexandre Ricard Stéphane Richard Kasper Rorsted Wilbur Ross Eric Schmidt George Soros Rupert Stadler Bernard Tapie Peter Terium Peter Thiel Patrick Thomas François Villeroy De Galhau Meg Whitman John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders